Zacks Investment Research on MSN
Wall Street analysts think Q32 Bio (QTTB) could surge 145.69%: Read this before placing a bet
Shares of Q32 Bio (QTTB) have gained 6% over the past four weeks to close the last trading session at $5.8, but there could ...
Q32 Bio (QTTB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
On Wednesday, Q32 Bio Inc. (NASDAQ:QTTB) revealed topline results from the SIGNAL-AA Phase 2a signal finding trial evaluating bempikibart (ADX-914) for alopecia areata (AA). The company plans to ...
4don MSN
This Q32 Bio analyst begins coverage on a bullish note; here are top 3 initiations for Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...
The latest price target for Q32 Bio (NASDAQ:QTTB) was reported by Wells Fargo on March 12, 2025. The analyst firm set a price target for $15.00 expecting QTTB to rise to within 12 months (a possible ...
Q32 Bio ( (QTTB)) has issued an announcement. On March 27, 2026, Q32 Bio Inc. entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co., enabling at-the-market sales of ...
Investors might want to bet on Q32 Bio (QTTB), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results